Global High-intensity Focused Ultrasound System Market Size By Type (Ultrasound-Guided, MR-Guided), By Application (HIFU for Disease, HIFU for Cosmetic), By Region, And Segment Forecasts, 2023 to 2032

The Global High-Intensity Focused Ultrasound (HIFU) System Market was valued at USD 410 million in 2023 and is projected to reach USD 910 million by 2031, growing at a CAGR of 10.2% from 2023 to 2031. The market is driven by the growing demand for non-invasive treatment options, rising prevalence of cancer and uterine fibroids, and increasing preference for outpatient therapeutic procedures. HIFU systems use focused ultrasound energy to generate localized heat, which can destroy targeted tissues with precision, making them a promising alternative to conventional surgical treatments.

Drivers:

Rising Adoption of Non-Invasive Procedures:

HIFU systems offer a non-invasive alternative to traditional surgical methods, which significantly reduces patient recovery time, lowers infection risk, and minimizes hospital stays. This has led to growing adoption in oncology, urology, and gynecology.

Increasing Prevalence of Cancer and Chronic Diseases:

The rising global incidence of cancers such as prostate and pancreatic cancer has intensified the need for innovative, targeted therapies. HIFU offers a promising solution for localized tumors, contributing to its increased adoption.

Technological Advancements in Imaging and Ultrasound Delivery:

Improved imaging techniques like MRI and real-time ultrasound have enhanced the precision and safety of HIFU procedures, broadening its applicability and acceptance among healthcare providers.

Restraints:

High Equipment Costs and Limited Reimbursement Policies:

HIFU systems require substantial capital investment and maintenance costs, which can hinder adoption in cost-sensitive and low-resource settings. Furthermore, inconsistent reimbursement policies globally limit their clinical integration.

Lack of Skilled Professionals:

The need for specialized training in HIFU operation and interpretation remains a barrier, especially in emerging economies where healthcare infrastructure is still developing.

Opportunity:

Expanding Applications in Neurology and Cosmetic Medicine:

Beyond oncology, HIFU is gaining traction in aesthetic medicine and neurological disorders like essential tremors. These novel applications are creating new revenue streams and expanding the market potential.

Growing Penetration in Emerging Markets:

Developing countries are increasingly investing in advanced medical technologies. With rising healthcare spending and demand for non-invasive treatments, regions like Asia-Pacific and Latin America present significant growth opportunities for HIFU system manufacturers.

Market by System Type Insights:

The market is segmented into MR-guided HIFU Systems and Ultrasound-guided HIFU Systems. In 2023, the Ultrasound-guided HIFU Systems segment held the largest market share due to its cost-effectiveness and widespread clinical usage. However, the MR-guided segment is expected to witness faster growth owing to superior imaging capabilities and treatment precision.

Market by End-Use Insights:

By end-use, the Hospitals segment dominated the market in 2023, driven by higher patient inflow and availability of advanced diagnostic and therapeutic infrastructure. The Ambulatory Surgical Centers (ASCs) segment is anticipated to grow at the fastest rate due to the rising trend toward outpatient procedures and reduced procedural costs.

Market by Regional Insights:

North America led the global market in 2023, supported by early technology adoption, strong healthcare infrastructure, and favorable regulatory support. Asia-Pacific is projected to witness the highest CAGR during the forecast period, driven by growing healthcare investments, increasing medical tourism, and heightened awareness of non-invasive treatment alternatives in countries like China, South Korea, and India.

Competitive Scenario:

Key players in the market include Chongqing Haifu Medical Technology Co., Ltd., SonaCare Medical, Insightec Ltd., EDAP TMS, Alpinion Medical Systems, FUS Instruments Inc., Profound Medical Corp., and Theraclion SA. These companies are actively engaging in product innovation, regulatory approvals, and strategic collaborations to enhance their global footprint.

Key Developments:

In 2023, Insightec received expanded FDA approval for its Exablate Neuro platform for the treatment of Parkinson’s disease symptoms.

EDAP TMS announced in 2024 the launch of its next-gen Focal One HIFU system with enhanced 3D imaging for prostate cancer treatment.

Profound Medical partnered with leading U.S. hospitals in 2023 to pilot its TULSA-PRO system for minimally invasive prostate ablation.

Scope of Work – Global High-Intensity Focused Ultrasound System Market

Report Metric Details

Market Size (2023) USD 410 million

Projected Market Size (2031) USD 910 million

CAGR (2023–2031) 10.2%

Market Segments System Type (MR-guided, Ultrasound-guided), End-use (Hospitals, ASCs)

Growth Drivers Rising demand for non-invasive procedures, increasing prevalence of cancer, advancements in imaging technologies